CN103704712B - Preparation method of Korean red ginseng buccal tablets - Google Patents
Preparation method of Korean red ginseng buccal tablets Download PDFInfo
- Publication number
- CN103704712B CN103704712B CN201410005923.6A CN201410005923A CN103704712B CN 103704712 B CN103704712 B CN 103704712B CN 201410005923 A CN201410005923 A CN 201410005923A CN 103704712 B CN103704712 B CN 103704712B
- Authority
- CN
- China
- Prior art keywords
- red ginseng
- korean red
- liquid extract
- aspartame
- korean
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 235000002789 Panax ginseng Nutrition 0.000 title claims abstract description 44
- 238000002360 preparation method Methods 0.000 title claims abstract description 9
- 239000006189 buccal tablet Substances 0.000 title abstract 2
- 239000000284 extract Substances 0.000 claims abstract description 29
- 239000000843 powder Substances 0.000 claims abstract description 15
- 108010011485 Aspartame Proteins 0.000 claims abstract description 14
- 239000000605 aspartame Substances 0.000 claims abstract description 14
- 235000010357 aspartame Nutrition 0.000 claims abstract description 14
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 claims abstract description 14
- 229960003438 aspartame Drugs 0.000 claims abstract description 14
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 claims abstract description 9
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims abstract description 9
- 229940041616 menthol Drugs 0.000 claims abstract description 9
- 239000000080 wetting agent Substances 0.000 claims abstract description 9
- 238000002156 mixing Methods 0.000 claims abstract description 8
- 239000007788 liquid Substances 0.000 claims description 25
- 235000009508 confectionery Nutrition 0.000 claims description 14
- 239000002245 particle Substances 0.000 claims description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 10
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 claims description 8
- 239000011122 softwood Substances 0.000 claims description 8
- 239000007937 lozenge Substances 0.000 claims description 7
- 239000000463 material Substances 0.000 claims description 5
- 239000000945 filler Substances 0.000 claims description 4
- 235000003599 food sweetener Nutrition 0.000 claims description 4
- 239000000314 lubricant Substances 0.000 claims description 4
- 239000003765 sweetening agent Substances 0.000 claims description 4
- 235000020985 whole grains Nutrition 0.000 claims description 4
- 244000126002 Ziziphus vulgaris Species 0.000 abstract description 4
- 235000013305 food Nutrition 0.000 abstract description 4
- 235000006545 Ziziphus mauritiana Nutrition 0.000 abstract description 2
- 235000008529 Ziziphus vulgaris Nutrition 0.000 abstract description 2
- 238000012827 research and development Methods 0.000 abstract description 2
- 239000012530 fluid Substances 0.000 abstract 3
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 abstract 2
- 229930195725 Mannitol Natural products 0.000 abstract 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 abstract 2
- 235000010355 mannitol Nutrition 0.000 abstract 2
- 239000000594 mannitol Substances 0.000 abstract 2
- 238000001035 drying Methods 0.000 abstract 1
- 239000008187 granular material Substances 0.000 abstract 1
- 235000019359 magnesium stearate Nutrition 0.000 abstract 1
- 238000004806 packaging method and process Methods 0.000 abstract 1
- 238000007873 sieving Methods 0.000 abstract 1
- 239000007779 soft material Substances 0.000 abstract 1
- 239000003826 tablet Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 14
- 230000001093 anti-cancer Effects 0.000 description 10
- 206010028980 Neoplasm Diseases 0.000 description 7
- 240000004371 Panax ginseng Species 0.000 description 7
- 235000008434 ginseng Nutrition 0.000 description 7
- 201000011510 cancer Diseases 0.000 description 6
- 235000013399 edible fruits Nutrition 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 4
- 239000000470 constituent Substances 0.000 description 4
- 230000003203 everyday effect Effects 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 244000269722 Thea sinensis Species 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 3
- 229930182490 saponin Natural products 0.000 description 3
- 150000007949 saponins Chemical class 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 229930192392 Mitomycin Natural products 0.000 description 2
- NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 description 2
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 2
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 2
- 235000003140 Panax quinquefolius Nutrition 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 230000007969 cellular immunity Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 208000014617 hemorrhoid Diseases 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 229960004857 mitomycin Drugs 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000001568 sexual effect Effects 0.000 description 2
- 235000014347 soups Nutrition 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 102000040350 B family Human genes 0.000 description 1
- 108091072128 B family Proteins 0.000 description 1
- 201000006474 Brain Ischemia Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 102100034279 Calcium-binding mitochondrial carrier protein Aralar2 Human genes 0.000 description 1
- 241001070941 Castanea Species 0.000 description 1
- 235000014036 Castanea Nutrition 0.000 description 1
- 206010008120 Cerebral ischaemia Diseases 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 244000025361 Ficus carica Species 0.000 description 1
- 235000008730 Ficus carica Nutrition 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 244000241838 Lycium barbarum Species 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- 244000241872 Lycium chinense Species 0.000 description 1
- 235000015468 Lycium chinense Nutrition 0.000 description 1
- 244000302512 Momordica charantia Species 0.000 description 1
- 235000009811 Momordica charantia Nutrition 0.000 description 1
- 235000009812 Momordica cochinchinensis Nutrition 0.000 description 1
- 235000018365 Momordica dioica Nutrition 0.000 description 1
- 208000015914 Non-Hodgkin lymphomas Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 244000018633 Prunus armeniaca Species 0.000 description 1
- 235000009827 Prunus armeniaca Nutrition 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 206010039491 Sarcoma Diseases 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 206010062129 Tongue neoplasm Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 208000025085 carcinoma of parotid gland Diseases 0.000 description 1
- -1 carrotene Proteins 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 208000023652 chronic gastritis Diseases 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 108010084210 citrin Proteins 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000012259 ether extract Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 235000021022 fresh fruits Nutrition 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 229930182494 ginsenoside Natural products 0.000 description 1
- 229940089161 ginsenoside Drugs 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 230000002650 habitual effect Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000007688 immunotoxicity Effects 0.000 description 1
- 231100000386 immunotoxicity Toxicity 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 235000020997 lean meat Nutrition 0.000 description 1
- 231100000225 lethality Toxicity 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 208000025036 lymphosarcoma Diseases 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000009245 menopause Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 230000035946 sexual desire Effects 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 235000013547 stew Nutrition 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 201000000498 stomach carcinoma Diseases 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 201000006134 tongue cancer Diseases 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 210000003556 vascular endothelial cell Anatomy 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/20—Agglomerating; Granulating; Tabletting
- A23P10/28—Tabletting; Making food bars by compression of a dry powdered mixture
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention belongs to the technical field of healthcare food research and development, and relates to a preparation method of Korean red ginseng buccal tablets, which comprises the following steps: uniformly mixing mannitol powder and Aspartame, and sieving with a 200-mesh sieve; uniformly mixing Korean red ginseng fluid extract, Chinese date fluid extract, fig fluid extract and the mannitol powder and Aspartame; adding a wetting agent to obtain a soft material; granulating, drying and straightening granules; adding menthol and magnesium stearate and mixing uniformly; and tabletting with a tablet press and packaging. The product provided by the invention has a body building function.
Description
Technical field
Health food research and development technical field belonging to the present invention.The present invention relates to a kind of preparation method of Korean red ginseng lozenge.Product of the present invention has the function improved the health.
Background technology
1 Korean red ginseng system is processed through steaming, toasting by the Koryo garden ginsent originating from Korea S, in processing Korean red ginseng process, has new anticancer active constituent to produce.Korean red ginseng is not cool not warm yet, belongs to warm nature; Though Korean ginseng is warm in nature but benefit property is strong, beneficial gas helps fire.Korean ginseng divides again white ginseng and red ginseng, and insufficiency of the spleen hyperactivity of fire person should use white ginseng, because of " life gas is cool, micro-bitter tonifying yin "; The timid person of insufficiency of the spleen lung should use red ginseng, " ripe temperature, the sweet yang-tonifying of taste ".On the whole, Korean ginseng is more suitable for the frank people of the old deficiency of vital energy and takes, the strong physique of energy, develop immunitypty.
Effect of Korean red ginseng:
(1) brain healthy: the people that failure of memory and sports coordination ability are declined and be on the drink or the food of contact zones alcohol component, the people of medicine, Korean red ginseng has and improves mental working ability, strengthens memory and improve effect of cerebral ischemia obstacle
(2) ease pain: some experts find by doing sensory nerve cell test, and Korean ginseng is all helpful to the various pain symptom of health.
(3) anti-cancer and anticancer: the saponin constituent of Korean red ginseng and non-saponin constituent have the proliferation activity suppressing multiple cancer cell, while also can inhibition cancer cell shift.In addition, Korean red ginseng and anticancer are with taking, and anticancer effect is better than independent anticancer (mitomycin).This is because cancer cell easily forms tolerance in chemotherapy of tumors, Korean red ginseng and anticancer, with taking, strengthen the lethality to cancer cell, alleviate the side effect of anticancer.
(4) develop immunitypty: Korean red ginseng extract can recover the cellular immunity the declined reaction because taking the anticancer (mitomycin) with immunotoxicity, especially ether extract can activate or strengthen cellular immunity, and the activity of NK, there is very large effect to raising immunity.
(5) diabetes are controlled: Korean red ginseng contains the material promoting insulin secretion and similar insulin action, and wherein ginsenoside can improve hyperglycaemia, effectively controls the generation of diabetes.
(6) strong liver: have antihepatitic activity in Korean ginseng composition, has the effect of removing toxic substances, protection liver and promotion liver regeneration, recovery.In addition, Korean red ginseng relieves the effect of alcohol in addition, eliminates the effect of being still drank after a night.
(7) regulate blood pressure: Korean red ginseng has hemangiectasis effect, can improve blood circulation, saponin constituent wherein, by promoting vascular endothelial cell release nitric oxide, can reach hypotensive activity.
(8) antifatigue and resistance to compression: find after deliberation, continues to take Korean red ginseng and can improve locomitivity and fatigue-relieving, to promoting that the recovery of player's fatigue accumulation and prevention exercise induced anemia have very great help; In addition, Korean red ginseng can also strengthen the tolerance to adverse environments such as low temperature (5 DEG C, O DEG C ,-10 DEG C) and high temperature (35 DEG C), by carrying out exquisite adjustment to pressure or environmental change, improves anti-pressure ability, maintains organism stability.
(9) improve Menopause obstacle: according to investigations, have the women of climacteric impairment property after taking Korean red ginseng, after having the people of 80% to admit to take Korean red ginseng, symptom is obviously improved.Expert claims, and these women, as adjusted consumption according to symptom, also can improve curative effect.
(10) male sexual disfunction is improved: Korean red ginseng can prevent the male sexual disfunction because pressure causes.Through clinical testing, after erectile dysfunction patient (90 people) takes Korean red ginseng, all make moderate progress in the degree of erection, sexual desire and satisfaction etc.
(11) anti-oxidant and anti-ageing: Korean red ginseng have suppress harmful active oxygen increase the antioxidant effect with lipid peroxidation.
2 date dates have another name called red date, dry jujube, Chinese date, originate from China, have the plantation history of more than 8,000 year in China, are just listed in since ancient times one of " five fruits " (chestnut, peach, Lee, apricot, jujube).Date is rich in the nutritional labelings such as protein, fat, carbohydrate, carrotene, B family vitamin, vitamin C, citrin and calcium, phosphorus, iron and CAMP.Wherein ascorbic content comes out at the top in fruit, has the laudatory title of vitamin king.
3 fig fig nature and flavor are sweet, flat, nontoxic.Containing fruit containing carbohydrate, citric acid, malic acid, acetic acid, enzyme etc.
Effect of fig:
Appetizing, antidiarrheal dysentery, controls five hemorrhoid: nourishing aperitive for relaxing, having galgctogogue action, having the merit of expelling parasite, anti-inflammatory, detumescence concurrently.Fruit branch and leaf all contain zymigen, can make assist digestion medicinal.
Fig relieve sore throat: fig two pieces, boiling water brews, for tea drink frequently; Fig fresh fruit dries to be ground into powder, blows bottleneck throat; Fig 15 grams, is taken after mixing with liquid in right amount with rock sugar after decocting, frequently drinks it for tea.
Fig is anticancer: fruit milk is to sarcoma, and lacteal tumor, gland cancer, leukaemia, lymphosarcoma all has inhibitory action.Clinically comprise tongue cancer with controlling all kinds of malignant tumour, lung cancer, carcinoma of parotid gland, cancer of the stomach, liver cancer, colon cancer, kidney etc.Food side: fresh fig 50 grams, 100 grams, lean meat, water stewes half an hour, takes soup and eats meat.Serve on a period of time, be no less than 30 days.Also can use fig 15 grams, boiling water brews for tea, everyday drink-service.
Fig hypoglycemic: Water Extract of Ficus Carica, has and reduces blood sugar effect.Food side: fig 15 grams, lycium barbarum 10 grams, is boiled in water.For tea-drinking, every day 1 dose, finally chew and take fig and the fruit of Chinese wolfberry.Also can use fig 50 grams, 100 grams, balsam pear, is all cut into sheet, adds poach soup, and seasoning can diet, serve on 7--10 days.
Fig stomach invigorating: fig ferment mixes with gastric juice, has aid digestion, but should eat raw.Appetite is not good enough person, every day can be chewed and be taken fig, each 1 piece, every day 3 times, is advisable with 1 hour ante cibum.To habitual constipation, hemorrhoid hemorrhage, the diseases such as chronic gastritis, clothes also effective.
Product of the present invention has the function improved the health.
Summary of the invention
1, a preparation method for Korean red ginseng lozenge, is characterised in that its following steps:
(1) material component percentage by weight be the Korean red ginseng liquid extract of 5-10%, the date liquid extract of 3-5%, the fig liquid extract of 2-5%, the sweet mellow wine powder of 70-80% be filler, the Aspartame of 3-5% is sweetener, the menthol of 1-3% is freshener, the dolomol of 1-3% is lubricant, the ethanol of appropriate 65-75% is wetting agent;
(2) sweet mellow wine powder in (1) and Aspartame are mixed, cross 200 mesh sieves for subsequent use;
(3) Korean red ginseng liquid extract, date liquid extract, fig liquid extract in (1) are mixed with sweet mellow wine powder in (2) and Aspartame, add wetting agent, make softwood;
(4) softwood in (3) is granulated by 16 mesh sieves;
(5) by the particle in (4) at 50-60 DEG C of dry 3-4h;
(6) particle in (5) is crossed the whole grain of 14 mesh sieve;
(7) particle in (6) is added menthol and dolomol mixing, add a cover vexed to 0.5-1h, with tabletting machine, pack.
According to the present invention, " % " in the present invention is percentage by weight.
Detailed description of the invention
The preparation method relating to a kind of Korean red ginseng lozenge of the present invention comprises following examples, and the following examples can further illustrate the present invention, but do not limit the present invention in any way.
Embodiment 1:
1, a preparation method for Korean red ginseng lozenge, is characterised in that its following steps:
(1) material component percentage by weight be the Korean red ginseng liquid extract of 10%, date liquid extract, the fig liquid extract of 2%, the sweet mellow wine powder of 80% of 3% be filler, 3% Aspartame be sweetener, 1% menthol be freshener, 1% dolomol be lubricant, the ethanol of appropriate 65% is wetting agent;
(2) sweet mellow wine powder in (1) and Aspartame are mixed, cross 200 mesh sieves for subsequent use;
(3) Korean red ginseng liquid extract, date liquid extract, fig liquid extract in (1) are mixed with sweet mellow wine powder in (2) and Aspartame, add wetting agent, make softwood;
(4) softwood in (3) is granulated by 16 mesh sieves;
(5) by the particle in (4) at 50 DEG C of dry 4h;
(6) particle in (5) is crossed the whole grain of 14 mesh sieve;
(7) particle in (6) is added menthol and dolomol mixing, add a cover vexed to 0.5h, with tabletting machine, pack.
Embodiment 2:
1, a preparation method for Korean red ginseng lozenge, is characterised in that its following steps:
(1) material component percentage by weight be the Korean red ginseng liquid extract of 5%, date liquid extract, the fig liquid extract of 5%, the sweet mellow wine powder of 80% of 5% be filler, 3% Aspartame be sweetener, 1% menthol be freshener, 1% dolomol be lubricant, the ethanol of appropriate 75% is wetting agent;
(2) sweet mellow wine powder in (1) and Aspartame are mixed, cross 200 mesh sieves for subsequent use;
(3) Korean red ginseng liquid extract, date liquid extract, fig liquid extract in (1) are mixed with sweet mellow wine powder in (2) and Aspartame, add wetting agent, make softwood;
(4) softwood in (3) is granulated by 16 mesh sieves;
(5) by the particle in (4) at 60 DEG C of dry 3h;
(6) particle in (5) is crossed the whole grain of 14 mesh sieve;
(7) particle in (6) is added menthol and dolomol mixing, add a cover vexed to 1h, with tabletting machine, pack.
Claims (1)
1. a preparation method for Korean red ginseng lozenge, is characterised in that its following steps:
(1) percentage by weight of material component is the Korean red ginseng liquid extract of 5-10%, the date liquid extract of 3-5%, the fig liquid extract of 2-5%, the sweet mellow wine powder of 70-80% be filler, the Aspartame of 3-5% is sweetener, the menthol of 1-3% is freshener, the dolomol of 1-3% is lubricant, and the ethanol of appropriate 65-75% is wetting agent;
(2) sweet mellow wine powder in (1) and Aspartame are mixed, cross 200 mesh sieves for subsequent use;
(3) Korean red ginseng liquid extract, date liquid extract, fig liquid extract in (1) are mixed with sweet mellow wine powder in (2) and Aspartame, add wetting agent, make softwood;
(4) softwood in (3) is granulated by 16 mesh sieves;
(5) by the particle in (4) at 50-60 DEG C of dry 3-4h;
(6) particle in (5) is crossed the whole grain of 14 mesh sieve;
(7) particle in (6) is added menthol and dolomol mixing, add a cover vexed to 0.5-1h, with tabletting machine, pack.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410005923.6A CN103704712B (en) | 2014-01-07 | 2014-01-07 | Preparation method of Korean red ginseng buccal tablets |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410005923.6A CN103704712B (en) | 2014-01-07 | 2014-01-07 | Preparation method of Korean red ginseng buccal tablets |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103704712A CN103704712A (en) | 2014-04-09 |
| CN103704712B true CN103704712B (en) | 2015-06-17 |
Family
ID=50398383
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410005923.6A Active CN103704712B (en) | 2014-01-07 | 2014-01-07 | Preparation method of Korean red ginseng buccal tablets |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103704712B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104187714B (en) * | 2014-08-07 | 2015-11-04 | 威海环翠楼红参科技有限公司 | A kind of preparation method of Korean red ginseng dietary fiber swelling powder |
| CN105661493A (en) * | 2016-01-04 | 2016-06-15 | 环翠楼红参生物科技股份有限公司 | Preparation method of Korean red ginseng lozenge |
| CN112274545A (en) * | 2020-11-17 | 2021-01-29 | 刘伟德 | Production process of red ginseng extract tablet |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1586248A (en) * | 2004-10-15 | 2005-03-02 | 高思 | Health drink |
| CN1593480A (en) * | 2004-07-02 | 2005-03-16 | 陈小保 | Fig buccal tablet and its preparing process |
| CN1653951A (en) * | 2005-03-09 | 2005-08-17 | 陕西科技大学 | Chinese date buccal tablet and its preparing process |
| WO2009070923A1 (en) * | 2007-11-30 | 2009-06-11 | Chi, Yu-Fen | A pharmaceutical composition for treating melancholy and preparation method thereof |
| CN101757112A (en) * | 2008-10-22 | 2010-06-30 | 于树丽 | Fig-American ginseng buccal tablet |
| KR100968955B1 (en) * | 2009-05-29 | 2010-07-14 | 충청대학 산학협력단 | Jujube pill and and method for manufacturing thereof |
| CN102302077A (en) * | 2011-08-26 | 2012-01-04 | 吉林紫鑫药业股份有限公司 | Ginseng candies and production process thereof |
-
2014
- 2014-01-07 CN CN201410005923.6A patent/CN103704712B/en active Active
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1593480A (en) * | 2004-07-02 | 2005-03-16 | 陈小保 | Fig buccal tablet and its preparing process |
| CN1586248A (en) * | 2004-10-15 | 2005-03-02 | 高思 | Health drink |
| CN1653951A (en) * | 2005-03-09 | 2005-08-17 | 陕西科技大学 | Chinese date buccal tablet and its preparing process |
| WO2009070923A1 (en) * | 2007-11-30 | 2009-06-11 | Chi, Yu-Fen | A pharmaceutical composition for treating melancholy and preparation method thereof |
| CN101757112A (en) * | 2008-10-22 | 2010-06-30 | 于树丽 | Fig-American ginseng buccal tablet |
| KR100968955B1 (en) * | 2009-05-29 | 2010-07-14 | 충청대학 산학협력단 | Jujube pill and and method for manufacturing thereof |
| CN102302077A (en) * | 2011-08-26 | 2012-01-04 | 吉林紫鑫药业股份有限公司 | Ginseng candies and production process thereof |
Non-Patent Citations (1)
| Title |
|---|
| 陈武,等.绞股蓝无糖口含片的制备工艺研究.《食品科学》.2008,第29卷(第3期),第245-248页. * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103704712A (en) | 2014-04-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103725572B (en) | Preparation method of red ginseng wine | |
| CN104824512A (en) | Fruit-coarse cereal electuary and preparation method thereof | |
| CN103609992B (en) | Preparation method of Korean red ginseng cream | |
| CN104171131A (en) | Dendrobium officinale and jasmine tea beverage and preparation method thereof | |
| CN103564300A (en) | Processing process of Korean red ginseng honey slices | |
| CN103689743B (en) | Method for preparing Korean-red-ginseng and mulberry beverage | |
| CN103704712B (en) | Preparation method of Korean red ginseng buccal tablets | |
| CN104738640A (en) | Preparation method of Korean red ginseng dietary fiber-soybean protein puffed powder | |
| CN103695274B (en) | Method for preparing Korean-ginseng wine | |
| CN103749827B (en) | Preparation method of red ginseng/fig tea | |
| CN103695275B (en) | Method for preparing Korean-ginseng and sea cucumber wine | |
| KR102267801B1 (en) | Composition of ssanghwa and method for preparing the same | |
| CN104187714B (en) | A kind of preparation method of Korean red ginseng dietary fiber swelling powder | |
| CN103704458B (en) | Processing technology of Korean ginseng honey slices | |
| CN103564572B (en) | Preparation method of Korean red ginseng soup | |
| CN103725467A (en) | Preparation method of ginseng red wine | |
| CN103689742B (en) | Method for preparing Korean-red-ginseng and fig beverage | |
| CN105524805A (en) | Preparation method for radix ginseng rubra and hericium erinaceus wine | |
| CN103719863B (en) | Preparation method of red ginseng chewable tablets | |
| CN103750425B (en) | Preparation method of red ginseng/fructus momordicae soup | |
| CN104719485B (en) | A kind of brown sugar red date milk tea powder and its preparation process | |
| CN103689602B (en) | Method for preparing Korean-red-ginseng oral liquid | |
| CN104738387A (en) | Preparation method of Korean red ginseng-soybean protein puffed powder | |
| CN103704459B (en) | Preparation method of Korean red ginseng hard candy | |
| CN103719499A (en) | Preparation method of red ginseng tea |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| PP01 | Preservation of patent right |
Effective date of registration: 20190905 Granted publication date: 20150617 |
|
| PP01 | Preservation of patent right | ||
| CP03 | Change of name, title or address | ||
| CP03 | Change of name, title or address |
Address after: 264200 No. 58, Taibei Road, Lingang Economic and Technological Development Zone, Weihai City, Shandong Province Patentee after: Shenyuanzhuang Biotechnology Co.,Ltd. Address before: No.58, Taibei Road, Lingang Economic and Technological Development Zone, Weihai City, Shandong Province Patentee before: WEIHAI HUANCUILOU RED GINSENG TECHNOLOGY Co.,Ltd. |
|
| PD01 | Discharge of preservation of patent | ||
| PD01 | Discharge of preservation of patent |
Date of cancellation: 20210905 Granted publication date: 20150617 |
|
| PP01 | Preservation of patent right | ||
| PP01 | Preservation of patent right |
Effective date of registration: 20240805 Granted publication date: 20150617 |